The CEO of MyXMO, Iris Tan had worked with Ministry of Health of Malaysia at Institute for Medical Research for 15 years, Pfizer for 10 years and MySMO for 7 years prior to joining MyXMO. She joined Pfizer, a leading pharmaceutical company in 1997 as a Regional CRA monitoring clinical trials conducted in Malaysia, Indonesia and Singapore, and as Clinical Study Manager, Clinical Research Manager managing/coordinating multicentre trials conducted in Asia Pacific region.
A seasoned clinical research professional with extensive experience in directing, planning and monitoring research projects and programs, she is well versed in the operational, regulatory and ethical aspect in conducting clinical trials in various therapeutics areas. She is well regarded and has achieved a reputation for ensuring high quality, timely and cost effective outputs in meeting the clinical research needs and standards.
Contracting and working on pharmaceutical sponsored research have become increasingly challenging and require comprehensive knowledge of good clinical practices, local regulatory requirements and sponsor’s Standard Operating Procedures (SOPs) and policies, Iris Tan has the capabilities and requisite skills to ensure that the aforementioned requirements of pharmaceutical company’s medical product development in clinical trials are met.
A self-starter, always focus on achieving results, Iris Tan has acquired sound knowledge through self-development. With an MBA degree, she has proven ability in solving problems, developing, motivating and leading teams.
She is currently a speaker for Good Clinical Practice (GCP) workshop organized by International Medical University, Hospital University Science Malaysia, International Islamic University Malaysia, University Putra Malaysia and etc.